Professor Andreas Obermair
Professor

Andreas Obermair

Email: 
Phone: 
+61 7 334 66044

Background

Professor Andreas Obermair is a gynaecological oncologist in public and private practice in Brisbane, Australia. He graduated from the University of Vienna, Austria (1990) and then went on to complete his specialist training in obstetrics and gynaecology (1999). He enrolled in gynaecological oncology sub-speciality training in 2000 (Brisbane and Perth) and since 2003 has been a part time staff specialist in gynaecological oncology at the Royal Brisbane and Women’s Hospital.

Professor Obermair is a NHMRC Investigator Fellow with the University of Queensland and is also the Director of Research in the Queensland Centre for Gynaecological Cancer where he drives a program of investigator-initiated surgical clinical trials. His mission is to make surgical treatments more humane, kinder and at the same time more effective.

His main research interests include clinical trials and hereditary (familial) gynaecological cancer. His main effort focusses on assembling a world-class team to conduct clinical trials that change the treatment of women affected by gynaecological cancer for the better. He authored more than 220 original articles in peer reviewed journals, teaches at the national and international level and maintains his international contacts at conferences. Professor Obermair conducts his private practice from Spring Hill in Brisbane, and on the Sunshine Coast.

Availability

Professor Andreas Obermair is:
Available for supervision

Fields of research

Biological Sciences Biomedical and Clinical Sciences Health Sciences Medical microbiology Oncology and carcinogenesis

Qualifications

  • Doctoral Diploma of Medicine, International University Vienna
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Research interests

  • Clinical Trials

    Decisions on cancer management ideally are based on the results of high-level evidence, obtained through clinical trials whenever possible. As a principle, a new (proposed better) intervention should be compared to the current standard treatment before being made available generally. Outside a clinical trial new treatments should not become available until evidence has become available to demonstrate superiority over the current standard treatment. Retrospective studies harbour the risk that biases influenced outcomes. At QCGC Research we engage in phase 2 and 3 clinical trials. In large phase trials, patients are allocated randomly to one of two or more interventions in order to minimise the risk of bias. Generally, patients treated within clinical trials have a better outcome compared to patients who are not treated in clinical trials. As the Director of Research Gynaecological Oncology I am currently involved in developing and managing clinical trials in gynaecological cancers.

  • Translational Research

    The focus of QCGC Research's translational research program is the application of new technology (molecular, biochemical, imaging and surgical) to prevention, detection and therapy for gynaecological cancers.

  • Quality of Life Research

    Cancer specialists are aware that not only the survival time but also the quality of life is a key factor in cancer treatment. This is especially important when two treatments are equally effective but cause different side-effects. My Quality-of-Life research focuses on ovarian, endometrial, cervical and vulval cancer. I wish to provide the best, most effective and modern treatment to my patients with least possible detriments to quality of life.

  • Minimally Invasive Surgery

    In Australia, around 30,000 hysterectomies are conducted annually to treat uterine cancer and various benign gynaecological conditions. While open abdominal surgery may be necessary in around 10% of cases, evidence shows that less-invasive approaches, such as total laparoscopic hysterectomy (TLH) can achieve better outcomes for women at a lower overall cost to the health system. Yet, in Queensland, four of ten hysterectomies are still conducted by open abdominal surgery. Our own research has shown that many Australian surgeons are keen to adopt new techniques such as TLH, but that the lack of systematic training and mentoring opportunities is the main impediment to practice-change. Together with gynaecological surgical teams at hospitals and industry support we developed a prototype for system-level transformative practice change in gynaecological surgery.

Research impacts

Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national impact of his research was recognised in 2017, when he was awarded Cancer Australia’s Jeannie Ferris Recognition Award (2017), for outstanding achievements in clinical practice and research. He is deeply engaged in consumer involvement and co-founded and serves on the Board of the Cherish Foundation, a consumer-focussed organisation that funds clinical research in better treatments for women with gynaecological cancers.

Search Professor Andreas Obermair’s works on UQ eSpace

386 works between 1991 and 2026
All (386) Journal Article (336) Other Outputs (2) Conference Publication (47) Book Chapter (1)

21 - 40 of 386 works

2025

Conference Publication

Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: results from the International Vulvar Cancer Consortium

Nasioudis, Dimitrios, Wohlmuth, Christoph, Albright, Benjamin, McDonald, Megan, Wallace, Sumer, Glickman, Ariel, Do, Anthony, Mantia-Smaldone, Gina, Grassi, Tommaso, Fleming, Elaine, Tsibulak, Irina, Reis, Ricardo Dos, Cucinella, Giuseppe, Heredia, Fernando, Pereira, Augusto, Bogani, Giorgio, Buckingham, Lindsey, Baiocchi, Glauco, Mills, Kathryn, AlHilli, Mariam, Obermair, Andreas, Covens, Allan, Mariani, Andrea, Plante, Marie and Giuntoli, Robert (2025). Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: results from the International Vulvar Cancer Consortium. 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer, Seattle, WA USA, 14-17 March 2025. Maryland Heights, MO USA: Academic Press. doi: 10.1016/j.ygyno.2025.03.075

Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: results from the International Vulvar Cancer Consortium

2025

Journal Article

Patterns of care for vulval cancer treatment: the Queensland experience

Davie, Stacey, Obermair, Andreas and West, Zoe Elizabeth (2025). Patterns of care for vulval cancer treatment: the Queensland experience. International Journal of Gynecological Cancer, 35 (7) 101956, 101956-101956. doi: 10.1016/j.ijgc.2025.101956

Patterns of care for vulval cancer treatment: the Queensland experience

2025

Journal Article

Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery

West, Simon, Jayasinghe, Dilki, Davie, Stacey and Obermair, Andreas (2025). Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery. International Journal of Gynecological Cancer, 35 (8) 101993, 101993. doi: 10.1016/j.ijgc.2025.101993

Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery

2025

Conference Publication

“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations

Campbell, Rachel, Jeon, Megan, Friedlander, Michael, King, Madeleine T., Obermair, Andreas, Bilic, Sanela, Brand, Alison, Butow, Phyllis, Codde, Jim, Gebski, Val, Goh, Jeffrey C., Ives, Angela, Lawson, Wanda, McNally, Orla, Meniawy, Tarek, Mileshkin, Linda R., Morton, Rachael L., Webb, Penelope M., Yates, Patsy and Cohen, Paul Andrew (2025). “The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations. 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16_suppl.12099

“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations

2025

Other Outputs

The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery

Obermair, Helena, Dissanayake, D. M. Sadrushi L. and Obermair, Andreas (2025). The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery. Brisbane, QLD, Australia: The University of Queensland. doi: 10.14264/3ddf262

The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery

2025

Journal Article

Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers

Tuesley, Karen M., Spilsbury, Katrina, Pearson, Sallie-Anne, Donovan, Peter, Obermair, Andreas, Coory, Michael D., Ali, Sitwat, Pandeya, Nirmala, Stewart, Louise, Jordan, Susan J. and Webb, Penelope M. (2025). Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers. JNCI: Journal of the National Cancer Institute, 117 (5) djae282, 1046-1055. doi: 10.1093/jnci/djae282

Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers

2025

Journal Article

A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma

Obermair, A., Gebski, V., Goh, J., Kuchel, A., Brand, A., Mak, B., McNally, O., Baxter, E., Jobling, T. and Mileshkin, L. (2025). A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer, 35 (4) 101644, 1-9. doi: 10.1016/j.ijgc.2025.101644

A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma

2025

Journal Article

Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer

Gersekowski, Kate, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas and Webb, Penelope M. (2025). Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer. Journal of Epidemiology and Community Health, 79 (9), 684-690. doi: 10.1136/jech-2024-222687

Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer

2025

Journal Article

What is the true prognosis of T1a cervical cancer?

Ng, Zheng Yuan, Manchanda, Ranjit, Lopez, Aldo, Obermair, Andreas, Dostalek, Lukas, Pareja, Rene, Van Lonkhuijzen, Luc R.c.w., Falconer, Henrik, Ortiz, David Isla, Fagotti, Anna, Ramirez, Pedro T., Landoni, Fabio, Weinberger, Vít, Laky, Rene, Kim, Sarah K., Klát, Jaroslav, Kocián, Roman, Nemejcova, Kristyna and Cibula, David (2025). What is the true prognosis of T1a cervical cancer?. International Journal of Gynecological Cancer, 35 (2 s1) 100442, 100442. doi: 10.1016/j.ijgc.2024.100442

What is the true prognosis of T1a cervical cancer?

2025

Journal Article

Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia

Na, Renhua, Jordan, Susan J., DeFazio, Anna, Williams, Merran, Livingstone, Karen, Obermair, Andreas, Friedlander, Michael, Grant, Peter, Webb, Penelope M. and for the OPAL Study Group (2025). Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia. International Journal of Cancer, 156 (2), 280-292. doi: 10.1002/ijc.35154

Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia

2025

Journal Article

The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims

Collings, Rachel, Potter, Christian, Gebski, Val, Janda, Monika and Obermair, Andreas (2025). The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims. American Journal of Obstetrics and Gynecology, 232 (1), 104.e1-104.e12. doi: 10.1016/j.ajog.2024.07.043

The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims

2024

Journal Article

Mild symptoms matter: results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer

Plinsinga, Melanie L., Rye, Sheree, Jones, Tamara, Vagenas, Dimitrios, Ward, Leigh, Janda, Monika, Obermair, Andreas and Hayes, Sandra C. (2024). Mild symptoms matter: results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer. Gynecologic Oncology, 191, 158-164. doi: 10.1016/j.ygyno.2024.10.011

Mild symptoms matter: results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer

2024

Journal Article

The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study

Ng, Zheng Yuan, Manchanda, Ranjit, Lopez, Aldo, Obermair, Andreas, Dostalek, Lukas, Pareja, Rene, van Lonkhuijzen, Luc R.C.W., Falconer, Henrik, Ortiz, David Isla, Fagotti, Anna, Ramirez, Pedro T., Landoni, Fabio, Weinberger, Vit, Laky, Rene, Kim, Sarah H., Klat, Jaroslav, Kocian, Roman, Pari, Darwin, Borcinova, Martina, Nemejcova, Kristyna and Cibula, David (2024). The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study. Gynecologic Oncology, 191, 95-99. doi: 10.1016/j.ygyno.2024.09.022

The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study

2024

Conference Publication

Outcomes of low-volume metastatic disease among patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy: Results from the International Vulvar Cancer Consortium (IVUCCO)

Nasioudis, Dimitrios, Grcevich, Leah, Albright, Benjamin, McDonald, Megan, Grassi, Tommaso, Zach, Diana, Wallace, Sumer, Tsibulak, Irina, Mantia-Smaldone, Gina, Anastasio, Mary Katherine, Reis, Ricardo Dos, AlHilli, Mariam, Do, Anthony, Baiocchi, Glauco, Cucinella, Giuseppe, Labban, Nayla, Gregorich, Nicole, Heredia, Fernando, Pereira, Augusto, Buckingham, Lindsey, Obermair, Andreas, Mariani, Andrea, Plante, Marie and Giuntoli, Robert (2024). Outcomes of low-volume metastatic disease among patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy: Results from the International Vulvar Cancer Consortium (IVUCCO). Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer and 2024 Winter Meeting, San Diego, CA United States, 16 - 18 March 2024. Maryland Heights, MO United States: Academic Press. doi: 10.1016/j.ygyno.2024.07.048

Outcomes of low-volume metastatic disease among patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy: Results from the International Vulvar Cancer Consortium (IVUCCO)

2024

Conference Publication

Are our exercise oncology guidelines fit-for-purpose for women with recurrent ovarian cancer? Results from a mixed methods exercise trial (the ECHO-R trial)

Hayes, Sandi, Janda, Monika, Eakin, Elizabeth, Shannon, Catherine, Goh, Jeffrey, Beesley, Vanessa, Vagenas, Dimitrios, Webb, Penny, Coward, Jermaine, Collins, Louisa, O'Neill, Helene, Rye, Sheree, Newton, Melissa, Gildea, Gabrielle, Plinsinga, Melanie, Sandler, Carolina, Jones, Tamara, Baniahmadi, Sara, Nascimento, Marcelo, Nicklin, James, Garret, Andrea, Obermair, Andreas and Spence, Rosa (2024). Are our exercise oncology guidelines fit-for-purpose for women with recurrent ovarian cancer? Results from a mixed methods exercise trial (the ECHO-R trial). COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13-15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Are our exercise oncology guidelines fit-for-purpose for women with recurrent ovarian cancer? Results from a mixed methods exercise trial (the ECHO-R trial)

2024

Conference Publication

The relationship between lower-limb lymphoedema and anxiety, depression, quality of life and overall survival post-gynaecological cancer

Plinsinga, Melanie L., Janda, Monika, Reul-Hirche, Hildegard, Vagenas, Dimitrios, Obermair, Andreas, Bloomquist, Kira and Hayes, Sandi (2024). The relationship between lower-limb lymphoedema and anxiety, depression, quality of life and overall survival post-gynaecological cancer. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD Australia, 13-15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

The relationship between lower-limb lymphoedema and anxiety, depression, quality of life and overall survival post-gynaecological cancer

2024

Conference Publication

EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis

Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551

EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis

2024

Conference Publication

The ECHO-R Exercise Trial For Recurrent Ovarian Cancer: Robust Evidence In An Understudied Population

Spence, Rosalind R., Janda, Monika, Eakin, Elizabeth, Shannon, Catherine, Goh, Jeffrey, Beesley, Vanessa, Vagenas, Dimitrios, Webb, Penelope, Coward, Jermaine, Collins, Louisa G., O'Neill, Helene, Williams, Merran, Rye, Sheree, Melissa, Newton, Gildea, Gabrielle, Plinsinga, Melanie, Sandler, Carolina, Jones, Tamara, Baniahmadi, Sara, Nascimento, Marcelo, Nicklin, James, Garret, Andrea, Obermair, Andreas and Hayes, Sandra C. (2024). The ECHO-R Exercise Trial For Recurrent Ovarian Cancer: Robust Evidence In An Understudied Population. American College of Sports Medicine Annual Meeting 2024, Boston, MA United States, 28 - 31 May 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1249/01.mss.0001060808.73204.e6

The ECHO-R Exercise Trial For Recurrent Ovarian Cancer: Robust Evidence In An Understudied Population

2024

Journal Article

LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer 

Ramirez, Pedro T., Robledo, Kristy P., Frumovitz, Michael, Pareja, Rene, Ribeiro, Reitan, Lopez, Aldo, Yan, Xiaojian, Isla, David, Moretti, Renato, Bernardini, Marcus Q., Gebski, Val, Asher, Rebecca, Behan, Vanessa, Coleman, Robert L. and Obermair, Andreas (2024). LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer . Journal of Clinical Oncology, 42 (23), 2741-2746. doi: 10.1200/jco.23.02335

LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer 

2024

Journal Article

Patients’ experiences of vulvar cancer diagnosis and treatment: results from a consumer-guided qualitative study

DiSipio, T., Johnston, M., Mellon, A., Williams, M., McQuire, L., Beller, E., Janda, M. and Obermair, A. (2024). Patients’ experiences of vulvar cancer diagnosis and treatment: results from a consumer-guided qualitative study. Cancer Survivorship Research & Care, 2 (1) 2368546, 1-16. doi: 10.1080/28352610.2024.2368546

Patients’ experiences of vulvar cancer diagnosis and treatment: results from a consumer-guided qualitative study

Current funding

  • 2026 - 2030
    Towards evidence-supported precision surgery for gynaecological cancer
    NHMRC Investigator Grants
    Open grant
  • 2025 - 2028
    The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
    Cherish Women's Cancer Foundation
    Open grant
  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2025 - 2026
    The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
    Cherish Women's Cancer Foundation
    Open grant
  • 2024 - 2029
    The EARLY study: Evaluating the Specificity and feasibility of the EARLY Test for Ovarian Cancer Detection
    NHMRC Partnership Projects
    Open grant
  • 2024 - 2027
    Moving without fear when living with stoma: A consumer-led physical activity study (MRFF CLR Grant administered by Flinders University)
    Griffith University
    Open grant
  • 2024 - 2029
    Salpingectomy with delayed oophorectomy to prevent ovarian cancer (TUBA WISP II) (MRFF ICTC Grant led by University of Melbourne)
    University of Melbourne
    Open grant
  • 2024 - 2027
    EN.10 - A Phase II study of adjuvant therapy in pole-mutated and p53-wildtype/NSWP early stage endometrial cancer (RAINBO BLUE & TAPER)
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2024 - 2028
    ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2023 - 2028
    Vulvar Cancer Feasibility Study: Establishing a novel pathway to best-practice treatment in vulvar cancer
    Research Donation Generic
    Open grant
  • 2010 - 2026
    QCOG (Data Manager Grant)
    Cancer Council Queensland
    Open grant

Past funding

  • 2024
    Moving without fear when living with stoma: A consumer-led physical activity study
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2024 - 2025
    Queensland Centre for Gynaecological Cancer's NODE Study
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2024
    Improving quality of life for vulvar cancer patients through non-invasive interventions
    Metro North Hospital and Health Service
    Open grant
  • 2022 - 2024
    Groin Lymph Node Involvement in Patients with Histologically Proven Vulvar Cancer
    ASGO Research Grants
    Open grant
  • 2022 - 2026
    A non-surgical alternative to hysterectomy for the treatment of endometrial cancer
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2024
    ECHO: A Phase III randomised, controlled trial of exercise during chemotherapy for patients commencing first line treatment for ovarian cancer (Cancer Council ACCRG led by Cancer Council Queensland)
    CCQ Accelerating Collaborative Cancer Research
    Open grant
  • 2021 - 2024
    MOST (Measure of Ovarian Symptoms and Treatment concerns)
    St John of God Healthcare Inc
    Open grant
  • 2021 - 2025
    Creating treatment options for endometrial cancer through high-level clinical trials
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2022
    A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial)
    Cherish Women's Cancer Foundation
    Open grant
  • 2020 - 2024
    A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith).
    Griffith University
    Open grant
  • 2020 - 2023
    Implementing non-surgical options for endometrial cancer treatment into clinical practice
    ICON Cancer Care
    Open grant
  • 2020 - 2021
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2020
    feMMe Long Term Follow-Up study
    ASGO Research Grants
    Open grant
  • 2019 - 2020
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2017 - 2020
    The Implementation of MinimAlly INvasivE hysterectomy (IMAGINE) trial
    NHMRC Partnership Projects
    Open grant
  • 2017 - 2018
    Transforming surgical practice through innovation IMAGINE
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2021
    The ECHO trial: Exercise during CHemotherapy for Ovarian cancer (World Cancer Research Fund International grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2021
    The Ovarian Cancer Prognosis and Lifestyle (OPAL) Study: Long-term outcomes (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2018
    Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial - survival outcomes
    Cancer Australia
    Open grant
  • 2016
    QCOG 2016
    Cancer Council Queensland
    Open grant
  • 2015 - 2019
    Cherish women's cancer foundation research fellow funding
    Cherish Women's Cancer Foundation
    Open grant
  • 2015 - 2022
    ECHO trial: Exercise during Chemotherapy for Ovarian cancer (Cancer Australia grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2018
    The fEMMe trial
    Cancer Australia
    Open grant
  • 2015 - 2016
    In Memory of Denise Marcella Collins
    Research Donation Generic
    Open grant
  • 2015 - 2016
    Impact of gated PET/CT on the diagnosis of distant metastases of advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2015 - 2019
    Selective targeting of adjuvant therapy for endometrial cancer: the STATEC trial (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2015
    Barriers of the uptake of laparoscopic hysterectomy
    Australian Centre for Health Services Innovation
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2014 - 2015
    Prophylactic surgery and breast cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2013 - 2020
    ACRF Molecular Oncology Translational Imaging Facility (MOTIF)
    Australian Cancer Research Foundation
    Open grant
  • 2013 - 2016
    Mirena ±Weight Loss to treat early Endometrial Cancer (MAxWEL Trial - Cancer Australia grant administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2013
    A phase II randomised clinical trial of mirena +/- metformin in patients with early stage cancer of the endometrium
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013
    QCOG 2013 (Data Manager Grants)
    Cancer Council Queensland
    Open grant
  • 2012 - 2023
    In Memory of Jan Sanders and other philanthropic donations
    Research Donation Generic
    Open grant
  • 2012 - 2013
    LEGS follow-up: Lymphoedema Evaluation following Gynaecology Cancer Study
    Queensland University of Technology
    Open grant
  • 2012 - 2013
    The effect of prophylactic, risk-reducing gynaecological surgery on survival among patients with a history of breast cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    HE 4 Collaborative Study
    Abbott Australasia Pty Ltd
    Open grant
  • 2011
    LEGS:Lymphoedema Evaluation in Gynaecological Cancer Study
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Wesley Merdical Research
    Open grant
  • 2010 - 2023
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal radical hysterectomy in patients with early stage cervical cancer (Clinical Trial Agreement)
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2010 - 2013
    Laparoscopic Approach to Carcinoma of the Endometrium. An international multicentre randomised Phase 3 clinical trial
    Cancer Australia
    Open grant
  • 2010 - 2013
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Cancer Australia
    Open grant
  • 2009 - 2011
    National Gynaecological Cancers Service Delivery and Resources Framework
    Cancer Australia
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Research & development into better standard of care for women experiencing gynaecological cancer
    Mayne Bequest Fund
    Open grant
  • 2009 - 2012
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2009 - 2010
    Cancer Clinical Trial Data Management Grant 2009
    Cancer Council Queensland
    Open grant
  • 2009 - 2010
    Post-operative enteral nutrition among patients with ovarian cancer
    Gallipoli Research Foundation
    Open grant
  • 2009
    Prognostic value of preoperative CA125 in ovarian tumours of low malignant potential
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2009 - 2010
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Gallipoli Research Foundation
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Wesley Merdical Research
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Cancer Australia
    Open grant
  • 2008 - 2009
    LACE - Laparoscopic Approach to Carcinoma of the Endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2008
    Cancer Clinical Trial Data Management grant 2008
    Queensland Cancer Fund
    Open grant
  • 2008
    Laparoscopic approach to cervical carcinoma -a phase III randomised clinical trial of laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients w/ early stage cervical cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic hysterectomy for Endometrial Cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007
    Cancer Clinical Trial Data Manager, QLD Centre for Gynaecological cancer - 2007
    Queensland Cancer Fund
    Open grant
  • 2007
    LACE- Laparoscopic approach to carcinoma of the endometrium - An international multicentre randomised phase 3 clinical trial - Top-Up funding
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer
    NHMRC Project Grant
    Open grant
  • 2006
    Cancer Clinical Trial Data Manager at the QLD Centre for Gynaecological Cancer
    Queensland Cancer Fund
    Open grant
  • 2006
    LACE - Laparoscopic approach to carinoma of the endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Queensland Cancer Fund
    Open grant
  • 2006 - 2007
    Total laparoscopic hysterectomy (TLH) vs Total Abdominal Hysterectomy (TAH) for the treatment of endometrial cancer
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Clinical Trial Data Manager
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Start-up Grant
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2004 - 2007
    Gynaecological Cancer Society Research Grants
    Gynaecological Cancer Society
    Open grant
  • 2004
    Mismatch repair gene defects in endometrial cancer patients less than 50 years of age
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant

Availability

Professor Andreas Obermair is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

Supervision history

Current supervision

  • Master Philosophy

    Patterns of care in endometrial cancer management in Queensland: a retrospective analysis.

    Principal Advisor

    Other advisors: Dr Eva Baxter

  • Doctor Philosophy

    Improving Quality of Survival for Women with Gynaecological Cancer

    Principal Advisor

    Other advisors: Dr Eva Baxter

  • Doctor Philosophy

    Improving care models for gynaecological cancer survivors

    Principal Advisor

    Other advisors: Dr Eva Baxter

  • Doctor Philosophy

    Advanced methods for biomarker informed endometrial cancer

    Principal Advisor

    Other advisors: Dr Eva Baxter, Dr Zoe West, Professor Andrew Martin

Completed supervision

Enquiries

For media enquiries about Professor Andreas Obermair's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au